Phylogeographic analysis on the travel-related introduction of HIV-1 non-B subtypes to Northern Poland

Infection, Genetics and Evolution

Volumn 27, Issue , 2014, Pages 121-130

  Parczewski, Milosz ^a   Urbanska, Anna ^a   Grzeszczuk, Anna ^b   Maciejewska, Katarzyna ^a   Witak Jedra, Magdalena ^a   Leszczyszyn Pynka, Magdalena ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

HIV 1 non B variants; Molecular surveillance; Phylogenetics; Phylogeography; Travelers

Indexed keywords

AIL GENE; AMPLICON; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; CONTROLLED STUDY; DNA EXTRACTION; FOXA GENE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HEP 2 CELL LINE; HORIZONTAL GENE TRANSFER; MICROTUS; MICROTUS FORTIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SHEEP; SPECIES INVASION; YERSINIA ENTEROCOLITICA; YERSINIA ENTEROCOLITICA 2006RAT; YERSINIA ENTEROCOLITICA SDWL 003; ADULT; CLASSIFICATION; FEMALE; GENETIC VARIATION; GENETICS; GENOTYPE; GEOGRAPHY; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MIDDLE AGED; MOLECULAR GENETICS; PHYLOGENY; PHYLOGEOGRAPHY; POLAND; RISK FACTOR; TRANSMISSION; TRAVEL; VIROLOGY; BRAZIL; CAMEROON; CENTRAL AFRICA; CENTRAL AFRICAN; DEMOCRATIC REPUBLIC CONGO; DISEASE TRANSMISSION; EASTERN EUROPE; EASTERN EUROPEAN; EUROPE; HETEROSEXUALITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE A; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE D; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE G; IMMIGRATION; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; PORTUGUESE (CITIZEN); SOUTH AFRICAN; SOUTH AMERICA; SOUTHEAST ASIAN; WEST AFRICAN;

ADULT; FEMALE; GENETIC VARIATION; GENOTYPE; GEOGRAPHY; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PHYLOGEOGRAPHY; POLAND; RISK FACTORS; TRAVEL;

EID: 84904886421     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.07.004     Document Type: Article

References (62)

1. HIV sequence database. 2012. <>. http://www.hiv.lanl.gov/components/sequence/HIV/geo/geo.comp.
2. Ustawa o Obywatelstwie Polskim (Polish Citizenship Act). Dziennik Ustaw Rzeczpospolitej Polskiej (Polish Journal of Laws of 2012) item 161, 1-15.
3. Aggarwal I., Smith M., Tatt I.D., Murad S., Osner N., Geretti A.M., Easterbrook P.J. Evidence for onward transmission of HIV-1 non-B subtype strains in the United Kingdom. J. Acquir. Immune Defic. Syndr. 2006, 41:201-209.
4. Anisimova M., Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst. Biol. 2006, 55:539-552.
5. Baeten J.M., Chohan B., Lavreys L., Chohan V., McClelland R.S., Certain L., Mandaliya K., Jaoko W., Overbaugh J. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J. Infect. Dis. 2007, 195:1177-1180.
6. Barlow K.L., Tatt I.D., Cane P.A., Pillay D., Clewley J.P. Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res. Hum. Retroviruses 2001, 17:467-474.
7. Bello G., Zanotto P.M., Iamarino A., Graf T., Pinto A.R., Couto-Fernandez J.C., Morgado M.G. Phylogeographic analysis of HIV-1 subtype C dissemination in Southern Brazil. PLoS One 2012, 7:e35649.
8. Bennett D.E., Camacho R.J., Otelea D., Kuritzkes D.R., Fleury H., Kiuchi M., Heneine W., Kantor R., Jordan M.R., Schapiro J.M., Vandamme A.M., Sandstrom P., Boucher C.A., van de Vijver D., Rhee S.Y., Liu T.F., Pillay D., Shafer R.W. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 2009, 4:e4724.
9. Brett-Major D.M., Hakre S., Naito N.A., Armstrong A., Bower E.A., Michael N.L., Scott P.T. Epidemiology of contemporary seroincident HIV infection in the Navy and Marine corps. Mil. Med. 2012, 177:1328-1334.
10. Buonaguro L., Petrizzo A., Tagliamonte M., Vitone F., Re M.C., Pilotti E., Casoli C., Sbreglia C., Perrella O., Tornesello M.L., Buonaguro F.M. Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. Infect. Agent Cancer 2008, 3:13.
11. Camacho, R., 2006. The significance of subtype-related genetic variability: controversies and unanswered questions. In: Geretti, A.M. (Ed.), Antiretroviral Resistance in Clinical Practice, London.
12. Chaix M.L., Descamps D., Harzic M., Schneider V., Deveau C., Tamalet C., Pellegrin I., Izopet J., Ruffault A., Masquelier B., Meyer L., Rouzioux C., Brun-Vezinet F., Costagliola D. Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. Aids 2003, 17:2635-2643.
13. de Sousa J.D., Alvarez C., Vandamme A.M., Muller V. Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1. Viruses 2012, 4:1950-1983.
14. Djoko C.F., Rimoin A.W., Vidal N., Tamoufe U., Wolfe N.D., Butel C., LeBreton M., Tshala F.M., Kayembe P.K., Muyembe J.J., Edidi-Basepeo S., Pike B.L., Fair J.N., Mbacham W.F., Saylors K.E., Mpoudi-Ngole E., Delaporte E., Grillo M., Peeters M. High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo. AIDS Res. Hum. Retroviruses 2011, 27:323-329.
15. Ferreira A.S., Cardoso L.P., Stefani M.M. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil. J. Med. Virol. 2011, 83:1301-1307.
16. Fihel, A., Kaczmarczyk, P., Stefanska, R., 2012. Recent trends in international migration in Poland. Central and Eastern European Migration Review, on-line publication <>. http://www.ceemr.uw.edu.pl/%201,%2069-90.
17. Fourati S., Malet I., Lambert S., Soulie C., Wirden M., Flandre P., Fofana D.B., Sayon S., Simon A., Katlama C., Calvez V., Marcelin A.G. E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure. Aids 2012, 26:1619-1624.
18. Gonzalez-Alba J.M., Holguin A., Garcia R., Garcia-Bujalance S., Alonso R., Suarez A., Delgado R., Cardenoso L., Gonzalez R., Garcia-Bermejo I., Portero F., de Mendoza C., Gonzalez-Candelas F., Galan J.C. Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis. J. Virol. 2011, 85:10755-10763.
19. Guindon S., Dufayard J.F., Lefort V., Anisimova M., Hordijk W., Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 2010, 59:307-321.
20. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000-2007. Aids 2011, 25:679-689.
21. Holguin A., de Mulder M., Yebra G., Lopez M., Soriano V. Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. Curr. HIV Res. 2008, 6:327-334.
22. Holmes E.C. The phylogeography of human viruses. Mol. Ecol. 2004, 13:745-756.
23. Hue S., Pillay D., Clewley J.P., Pybus O.G. Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4425-4429.
24. Hughes G.J., Fearnhill E., Dunn D., Lycett S.J., Rambaut A., Leigh Brown A.J. Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog. 2009, 5:e1000590.
25. Katzenstein D. Diversity, drug resistance, and the epidemic of subtype C HIV-1 in Africa. J. Infect. Dis. 2006, 194(Suppl 1):S45-S50.
26. Kousiappa I., Achilleos C., Hezka J., Lazarou Y., Othonos K., Demetriades I., Kostrikis L.G. Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance. AIDS Res. Hum. Retroviruses 2011, 27:1183-1199.
27. Lamers S.L., Poon A.F., McGrath M.S. HIV-1 nef protein structures associated with brain infection and dementia pathogenesis. PLoS One 2011, 6:e16659.
28. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
29. Lasky M., Perret J.L., Peeters M., Bibollet-Ruche F., Liegeois F., Patrel D., Molinier S., Gras C., Delaporte E. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. Aids 1997, 11:43-51.
30. Lazouskaya N.V., Eremin V.F., Adema K.W., Gasich E.L., Baan E., Lukashov V.V. The HIV type 1 epidemic in Belarus: predominance of Eastern European subtype A strains and circulation of subtype B viruses. AIDS Res. Hum. Retroviruses 2005, 21:830-833.
31. Liitsola K., Tashkinova I., Laukkanen T., Korovina G., Smolskaja T., Momot O., Mashkilleyson N., Chaplinskas S., Brummer-Korvenkontio H., Vanhatalo J., Leinikki P., Salminen M.O. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. Aids 1998, 12:1907-1919.
32. Liu T.F., Shafer R.W. Web resources for HIV type 1 genotypic-resistance test interpretation. Clin. Infect. Dis. 2006, 42:1608-1618.
33. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., Ingersoll R., Sheppard H.W., Ray S.C. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 1999, 73:152-160.
34. Los Alamos National Laboratory.Theoretical Biology and Biophysics Group T-10 HIV Sequence Compendium 2012, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
35. Lukashov V.V., Huismans R., Rakhmanova A.G., Lisitsina Z.N., Akhtyrskaya N.A., Vlasov N.N., Melnick O.B., Goudsmit J. Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. AIDS Res. Hum. Retroviruses 1999, 15:1577-1583.
36. Lutalo T., Gray R.H., Wawer M., Sewankambo N., Serwadda D., Laeyendecker O., Kiwanuka N., Nalugoda F., Kigozi G., Ndyanabo A., Bwanika J.B., Reynolds S.J., Quinn T., Opendi P. Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda. Aids 2007, 21(Suppl. 6):S15-S19.
37. Niedzwiedzka-Stadnik M., Rosinska M. HIV and AIDS in Poland in 2010. Przegl. Epidemiol. 2012, 66:315-323.
38. Novitsky V.A., Montano M.A., Essex M. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. AIDS Res. Hum. Retroviruses 1998, 14:1079-1085.
39. Office of Central Statistics, Poland, 2012a. Demographic Yearbook of Poland 2012. On-line: <>. http://www.stat.gov.pl/cps/rde/xbcr/gus/sy_demographic_yearbook_2012.pdf.
40. Office of Central Statistics, Poland, 2012b. [Information about the size and directions of Polish emigration in the years 2004-2011] - in Polish. On-line: <>. http://www.stat.gov.pl/cps/rde/xbcr/gus/LU_infor_o_rozm_i_kierunk_emigra_z_polski_w_latach_2004_2011.pdf.
41. Parczewski M., Leszczyszyn-Pynka M., Bander D., Urbanska A., Boron-Kaczmarska A. HIV-1 subtype D infections among Caucasians from Northwestern Poland-Phylogenetic and clinical analysis. PLoS One 2012, 7:e31674.
42. Parczewski M., Leszczyszyn-Pynka M., Bander D., Urbanska A., Stanczak G., Boron-Kaczmarska A. Characteristics of HIV-1 non-B subtype infections in Northwest Poland. J. Med. Virol. 2010, 82:1306-1313.
43. Patrascu I.V., Dumitrescu O. The epidemic of human immunodeficiency virus infection in Romanian children. AIDS Res. Hum. Retroviruses 1993, 9:99-104.
44. Pillay V., Ledwaba J., Hunt G., Rakgotho M., Singh B., Makubalo L., Bennett D.E., Puren A., Morris L. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Antivir. Ther. 2008, 13(Suppl 2):101-107.
45. Ramirez-Piedad M.K., Lepej S.Z., Yerly S., Begovac J. High prevalence of non-B HIV-1 subtypes in seamen and their sexual partners in Croatia. J. Med. Virol. 2009, 81:573-577.
46. Reigadas S., Marcelin A.G., Houssaini A., Yerly S., Descamps D., Plantier J.C., Ruffault A., Amiel C., Trabaud M.A., Flandre P., Fleury H., Masquelier B. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes. J. Antimicrob. Chemother. 2013, 68:969-972.
47. Rosinska M., Zielinski A. Recent increase in HIV rate by age, cohort, period analysis of surveillance data suggests changes in HIV epidemiology in Poland. Cent. Eur. J. Public Health 2011, 19:123-127.
48. Roudinskii N.I., Sukhanova A.L., Kazennova E.V., Weber J.N., Pokrovsky V.V., Mikhailovich V.M., Bobkov A.F. Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations. J. Virol. 2004, 78:11276-11287.
49. Salemi M., de Oliveira T., Ciccozzi M., Rezza G., Goodenow M.M. High-resolution molecular epidemiology and evolutionary history of HIV-1 subtypes in Albania. PLoS One 2008, 3:e1390.
50. Scott P.T., Hakre S., Myles O., Sanders-Buell E.E., Kijak G.H., McCutchan F.E., O'Connell R.J., Peel S.A., Eggleston J.C., Sateren W.B., Robb-McGrath M., Mott R.L., Tobler S.K., Nolan E., Petruccelli B.P., Michael N.L., Cersovsky S.B. Short communication: investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007. AIDS Res. Hum. Retroviruses 2012, 28:1308-1312.
51. Shafer R.W., Rhee S.Y., Pillay D., Miller V., Sandstrom P., Schapiro J.M., Kuritzkes D.R., Bennett D. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. Aids 2007, 21:215-223.
52. Smolen-Dzirba J., Rosinska M., Kruszynski P., Bratosiewicz-Wasik J., Janiec J., Beniowski M., Bociaga-Jasik M., Jablonowska E., Szetela B., Porter K., Wasik T.J. Molecular epidemiology of recent HIV-1 infections in Southern Poland. J. Med. Virol. 2012, 84:1857-1868.
53. Taylor B.S., Sobieszczyk M.E., McCutchan F.E., Hammer S.M. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 2008, 358:1590-1602.
54. Thomson M.M., Najera R. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin. Infect. Dis. 2001, 32:1732-1737.
55. Thomson M.M., Vinogradova A., Delgado E., Rakhmanova A., Yakovlev A., Cuevas M.T., Munoz M., Pinilla M., Vega Y., Perez-Alvarez L., Osmanov S., Najera R. Molecular epidemiology of HIV-1 in St Petersburg, Russia: predominance of subtype A, former Soviet Union variant, and identification of intrasubtype subclusters. J. Acquir. Immune Defic. Syndr. 2009, 51:332-339.
56. Vachot L., Ataman-Onal Y., Terrat C., Durand P.Y., Ponceau B., Biron F., Verrier B. Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples. AIDS Res. Hum. Retroviruses 2004, 20:687-691.
57. Vercauteren J., Derdelinckx I., Sasse A., Bogaert M., Ceunen H., De Roo A., De Wit S., Deforche K., Echahidi F., Fransen K., Goffard J.C., Goubau P., Goudeseune E., Yombi J.C., Lacor P., Liesnard C., Moutschen M., Pierard D., Rens R., Schrooten Y., Vaira D., van den Heuvel A., van der Gucht B., van Ranst M., van Wijngaerden E., Vandercam B., Vekemans M., Verhofstede C., Clumeck N., Vandamme A.M., van Laethem K. Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. AIDS Res. Hum. Retroviruses 2008, 24:355-362.
58. Vercauteren J., Wensing A.M., van de Vijver D.A., Albert J., Balotta C., Hamouda O., Kucherer C., Struck D., Schmit J.C., Asjo B., Bruckova M., Camacho R.J., Clotet B., Coughlan S., Grossman Z., Horban A., Korn K., Kostrikis L., Nielsen C., Paraskevis D., Poljak M., Puchhammer-Stockl E., Riva C., Ruiz L., Salminen M., Schuurman R., Sonnerborg A., Stanekova D., Stanojevic M., Vandamme A.M., Boucher C.A. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J. Infect. Dis. 2009, 200:1503-1508.
59. Worobey M., Gemmel M., Teuwen D.E., Haselkorn T., Kunstman K., Bunce M., Muyembe J.J., Kabongo J.M., Kalengayi R.M., Van Marck E., Gilbert M.T., Wolinsky S.M. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008, 455:661-664.
60. Yebra G., de Mulder M., Martin L., Rodriguez C., Labarga P., Viciana I., Berenguer J., Aleman M.R., Pineda J.A., Garcia F., Holguin A. Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naive HIV-infected patients (CoRIS) are due to recombinant viruses. J. Clin. Microbiol. 2012, 50:407-413.
61. Yerly S., Jost S., Monnat M., Telenti A., Cavassini M., Chave J.P., Kaiser L., Burgisser P., Perrin L. HIV-1 co/super-infection in intravenous drug users. Aids 2004, 18:1413-1421.
62. Zetterberg V., Ustina V., Liitsola K., Zilmer K., Kalikova N., Sevastianova K., Brummer-Korvenkontio H., Leinikki P., Salminen M.O. Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. AIDS Res. Hum. Retroviruses 2004, 20:1148-1156.